STADE-HF (sST2 As a help for management of HF): a pilot study

Huet, F; Nicoleau, J; Dupuy, AM; Curinier, C; Breuker, C; Castet-Nicolas, A; Lotierzo, M; Kalmanovich, E; Zerkowski, L; Akodad, M; Adda, JM; Agullo, A; Leclercq, F; Pasquie, JL; Battistella, P; Roubille, C; Fesler, P; Mercier, G; Bourel, G; Cristol, JP; Roubille, F

Roubille, F (corresponding author), Univ Montpellier I, CHU Montpellier, Hop Arnaud de Villeneuve, Dept Cardiol,UFR Med, 371 Ave Doyen Gaston Giraud, F-34295 Montpellier 05, France.

ESC HEART FAILURE, 2020; 7 (2): 774

Abstract

Aims Biomarkers are not recommended until now to guide the management of patients with heart failure (HF). Soluble suppression of tumorigenicity 2 (sS......

Full Text Link